Up-regulation of JCAD inhibits the ability of LATS2 to phosphorylate YAP, thus elevating CCND1 and Gli2 expression to promote hepatoma cell proliferation [31]. The gene discussed is GLI2; the disease is hepatocellular carcinoma.